ALTEOGEN Inc. (KOSDAQ:196170)
166,800
-4,100 (-2.40%)
Nov 19, 2026, 11:40 AM KST
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 11.61 trillion as of November 18, 2026. It is the 2,298th most valuable company in the world and the 51st biggest in South Korea. Its market cap has decreased by 61.15% in one year.
Market Cap
11.61T
Enterprise Value
11.28T
Revenue
254.01B
Global Rank
Country Rank
#51 South Korea
PE Ratio
63.90
ChartMarket Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 11.61T, an increase of 9,581.35%. That is a compound annual growth rate of 46.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 11.61T | -51.69% |
| Dec 30, 2025 | 24.04T | 45.74% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 65.57T |
| Celltrion | 49.11T |
| Samsung Epis Holdings | 8.90T |
| SK Biopharmaceuticals | 6.95T |
| HLB Co., Ltd. | 3.79T |
| SK bioscience | 3.05T |
| ABL Bio | 2.19T |
| Hugel | 2.13T |